What question did this study set out to answer?

This study aims to optimize anemia management in hemodialysis patients using the Dialysis Anemia Treatment Model.

March 28, 2026Open Access

WCN26-3831 Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients with End-Stage Kidney Disease Using the Dialysis Anemia TReatmenT Model” (SMART study)

Key Points

This study aims to optimize anemia management in hemodialysis patients using the Dialysis Anemia Treatment Model.
Conducted clinical validation of a new management model for anemia in hemodialysis patients.
Utilized a pixel array urine biosensor for assessing renal health.
Assessed the relationship between urinary TMAO and albuminuria as biomarkers.
The new biosensor provided rapid and precise assessments of kidney health.
Strong correlation observed between urinary TMAO levels and albuminuria was found, indicating its potential for early detection of diabetic kidney disease.
Demonstrated a minimally invasive approach for kidney monitoring in patients.

Abstract

of TMAO and glucose, supporting its applicability for rapid, lowvolume point-of-care testing.Conclusion: This pixel array urine biosensor offers a rapid, precise, and minimally invasive platform for assessing renal metabolic injury in diabetes.The strong linkage between urinary TMAO and albuminuria underscores its potential as a point-of-care diagnostic platform for early DKD detection and precision kidney health monitoring.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

Bookmark

View Full Paper

Bookmark

View Full Paper

WCN26-3831 Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients with End-Stage Kidney Disease Using the Dialysis Anemia TReatmenT Model” (SMART study)

Key Points

Abstract

Cite This Study